The authors compared TQ-SLNs, free TQ, and SILYBON® formulations for protection against liver cirrhosis induced by paracetamol, and they found that TQ-SLNs significantly decreased serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), and alkaline phosphatase (ALP) (Figure 4). Here, GPT is linked to cirrhosis of liver.